Cullinan Therapeutics, Inc. (CGEM) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
CGEM Historical Performance
Short-Term Returns
CGEM Stock Price Trajectory (2021–2026)
As of May 8, 2026, Cullinan Therapeutics, Inc. (CGEM) trades at $14.72, representing a +91.2% return over the past year. The stock has delivered a -50.7% total return over five years (-13.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $59.85 on March 10, 2021. From this peak, CGEM has corrected -75.4%, currently trading 41% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers IMVT (+96.1% 1Y), KYMR (+190.7% 1Y), and RCUS (+209.6% 1Y), CGEM has underperformed the peer group average. Compare CGEM vs IMVT →
CGEM Historical Price Data (2025–2026)
Showing 30 of 1,339 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 14.93 | 14.93 | 14.09 | 14.72 | 1.23M | -1.80% |
| 2026-05-06 | 14.90 | 15.30 | 14.55 | 14.99 | 574K | +0.33% |
| 2026-05-05 | 15.50 | 15.75 | 14.21 | 14.94 | 871K | -2.61% |
| 2026-05-04 | 13.66 | 15.88 | 13.60 | 15.34 | 1.66M | +14.22% |
| 2026-05-01 | 13.26 | 13.66 | 12.89 | 13.43 | 511K | +2.91% |
| 2026-04-30 | 12.70 | 13.14 | 12.64 | 13.05 | 291K | +1.56% |
| 2026-04-29 | 12.71 | 13.11 | 12.42 | 12.85 | 712K | +0.31% |
| 2026-04-28 | 13.40 | 13.60 | 12.69 | 12.81 | 503K | -3.32% |
| 2026-04-27 | 13.22 | 14.32 | 13.20 | 13.25 | 584K | +0.23% |
| 2026-04-24 | 12.86 | 13.35 | 12.56 | 13.22 | 589K | +2.08% |
| 2026-04-23 | 13.85 | 14.07 | 12.86 | 12.95 | 523K | -6.43% |
| 2026-04-22 | 14.41 | 14.43 | 13.63 | 13.84 | 472K | -2.67% |
| 2026-04-21 | 14.53 | 14.54 | 14.10 | 14.22 | 662K | -2.07% |
| 2026-04-20 | 14.82 | 15.04 | 14.39 | 14.52 | 491K | -3.59% |
| 2026-04-17 | 15.00 | 15.20 | 14.77 | 15.06 | 835K | +2.17% |
| 2026-04-16 | 15.02 | 15.09 | 14.63 | 14.74 | 407K | -1.40% |
| 2026-04-15 | 14.41 | 15.07 | 14.40 | 14.95 | 965K | +4.18% |
| 2026-04-14 | 14.30 | 14.65 | 14.21 | 14.35 | 873K | +0.70% |
| 2026-04-13 | 14.47 | 15.04 | 13.75 | 14.25 | 1.11M | -1.99% |
| 2026-04-10 | 15.06 | 15.31 | 14.41 | 14.54 | 368K | -4.40% |
| 2026-04-09 | 14.82 | 15.22 | 14.80 | 15.21 | 527K | +1.67% |
| 2026-04-08 | 15.32 | 15.66 | 14.30 | 14.96 | 611K | +0.67% |
| 2026-04-07 | 14.76 | 14.95 | 14.33 | 14.86 | 448K | -0.40% |
| 2026-04-06 | 14.47 | 15.57 | 14.46 | 14.92 | 1.04M | +3.40% |
| 2026-04-02 | 13.83 | 14.62 | 13.51 | 14.43 | 1.14M | +3.52% |
| 2026-04-01 | 14.30 | 14.81 | 13.92 | 13.94 | 656K | -1.90% |
| 2026-03-31 | 13.66 | 14.52 | 13.52 | 14.21 | 582K | +5.89% |
| 2026-03-30 | 12.76 | 13.50 | 12.64 | 13.42 | 716K | +4.44% |
| 2026-03-27 | 13.74 | 13.74 | 12.84 | 12.85 | 593K | -6.00% |
| 2026-03-26 | 13.88 | 14.29 | 13.62 | 13.67 | 648K | -2.77% |
See CGEM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CGEM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CGEM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCGEM — Frequently Asked Questions
Quick answers to the most common questions about buying CGEM stock.
How has CGEM stock performed recently?
CGEM returned +91.2% over the past year, beating its 5-year annualized CAGR of -13.2%. The stock trades above its 200-day moving average, confirming the uptrend.
What is CGEM's all-time high price?
Cullinan Therapeutics, Inc. reached $59.85 on 2021-03-10. The 52-week high is $16.74. Current 1-year return of +91.2% places the stock closer to historical peaks.
Where can I download CGEM historical price data?
This page provides CGEM daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.